Not applicableLooking for participantsNCT05668351What this trial is testingStereotactic Ablative Radiation Therapy for Prostate CancerWho this might be right forProstate Cancer Medical University of South Carolina 36
Testing effectiveness (Phase 2)Study completedNCT01090466What this trial is testingGemcitabine Hydrochloride, Cisplatin, and Temsirolimus as First-Line Therapy in Treating Patients With Locally Advanced and/or Metastatic Transitional Cell Cancer of the UrotheliumWho this might be right forBladder CancerTransitional Cell Cancer of the Renal Pelvis and UreterUrethral Cancer Cardiff University 15
Testing effectiveness (Phase 2)Study completedNCT00006111What this trial is testingSurgery Plus Combination Chemotherapy and Radiation Therapy in Treating Patients With Cancer of the Urinary TractWho this might be right forBladder CancerTransitional Cell Cancer of the Renal Pelvis and UreterUrethral Cancer UNICANCER 53
Testing effectiveness (Phase 2)Study completedNCT00002914What this trial is testingPiritrexim in Treating Patients With Advanced Cancer of the Urinary TractWho this might be right forBladder CancerTransitional Cell Cancer of the Renal Pelvis and UreterUrethral Cancer Eastern Cooperative Oncology Group 40
Testing effectiveness (Phase 2)Active Not RecruitingNCT06638931What this trial is testingAgnostic Therapy in Rare Solid TumorsWho this might be right forUrachal CancerParathyroid CarcinomaFibrolamellar Carcinoma+38 more Instituto do Cancer do Estado de São Paulo 28
Testing effectiveness (Phase 2)Looking for participantsNCT05888532What this trial is testing64Cu-GRIP B in Patients With Advanced MalignanciesWho this might be right forProstate CancerRenal CancerUrethral Cancer+3 more Rahul Aggarwal 91
Testing effectiveness (Phase 2)Study completedNCT00055835What this trial is testingS0121, Neoadjuvant Carboplatin, Paclitaxel, and Gemcitabine Followed by Cisplatin and Radiation Therapy in Treating Patients With Locally Advanced or Recurrent Carcinoma of the UrotheliumWho this might be right forBladder CancerUrethral Cancer SWOG Cancer Research Network 7
Testing effectiveness (Phase 2)Study completedNCT00397488What this trial is testingSunitinib in Treating Patients With Progressive Metastatic Transitional Cell Cancer of the UrotheliumWho this might be right forBladder CancerTransitional Cell Cancer of the Renal Pelvis and UreterUrethral Cancer Memorial Sloan Kettering Cancer Center 78
Testing effectiveness (Phase 2)Study completedNCT00005644What this trial is testingCombination Chemotherapy in Treating Patients With Advanced Cancer of the Urothelium and Decreased Kidney FunctionWho this might be right forBladder CancerTransitional Cell Cancer of the Renal Pelvis and UreterUrethral Cancer Eastern Cooperative Oncology Group
Testing effectiveness (Phase 2)Study completedNCT00661609What this trial is testingA Phase II Study of AZD4877 (a Novel Anti-mitotic Agent) in Advanced Bladder CancerWho this might be right forBladder CancerTransitional Cell Bladder CancerUrethra Cancer+2 more AstraZeneca 54
Large-scale testing (Phase 3)Study completedNCT00014274What this trial is testingCombination Chemotherapy in Treating Patients With Transitional Cell Cancer of the UrotheliumWho this might be right forBladder CancerTransitional Cell Cancer of the Renal Pelvis and UreterUrethral Cancer European Organisation for Research and Treatment of Cancer - EORTC 238
Testing effectiveness (Phase 2)Study completedNCT04602078What this trial is testingStudy of Atezolizumab Combined With Split-dose Gemcitabine Plus Cisplatin in Urothelial CarcinomaWho this might be right forLocally Advanced or Metastatic Urothelial Carcinoma Spanish Oncology Genito-Urinary Group 82
Testing effectiveness (Phase 2)Active Not RecruitingNCT00082706What this trial is testingFluorouracil, Leucovorin, Gemcitabine, and Cisplatin in Treating Patients With Metastatic or Unresectable Adenocarcinoma of the Urothelium or Urachal RemnantWho this might be right forBladder CancerUrethral CancerUrachal Cancer M.D. Anderson Cancer Center 46
Testing effectiveness (Phase 2)Study completedNCT01688999What this trial is testingCabozantinib for Advanced Urothelial CancerWho this might be right forUrothelial CarcinomaUrethral NeoplasmsUrinary Bladder Neoplasms+1 more National Cancer Institute (NCI) 69
Early research (Phase 1)Study completedNCT00082719What this trial is testingShort-Term Low-Dose Interferon Alfa in Treating Patients With Cancer of the UrotheliumWho this might be right forBladder CancerUrethral Cancer M.D. Anderson Cancer Center 33
Early research (Phase 1)Study completedNCT00020579What this trial is testingMS-275 in Treating Patients With Advanced Solid Tumors or LymphomaWho this might be right forCancer National Institutes of Health Clinical Center (CC) 75
Large-scale testing (Phase 3)Looking for participantsNCT05987241What this trial is testingTesting the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Removal of the Bladder, Kidney, Ureter, and Urethra for Urothelial Cancer Treatment, MODERN StudyWho this might be right forMuscle Invasive Bladder Urothelial CarcinomaMuscle Invasive Renal Pelvis Urothelial CarcinomaMuscle Invasive Ureter Urothelial Carcinoma+4 more National Cancer Institute (NCI)
Early research (Phase 1)Study completedNCT00049296What this trial is testingThalidomide and Docetaxel in Treating Patients With Advanced CancerWho this might be right forCancer Case Comprehensive Cancer Center 26
Not applicableStudy completedNCT02570919What this trial is testingPhase II Study of Ultra-high-dose Hypofractionated vs. Single-dose Image-Guided Radiotherapy for Prostate CancerWho this might be right forPROSTATE CANCER Fundacao Champalimaud 30
Testing effectiveness (Phase 2)Ended earlyNCT02612194What this trial is testingLCI-GU-URO-CRI-001: Crizotinib in Patients With c-MET or RON-Positive Metastatic Urothelial CancerWho this might be right forUrinary Bladder NeoplasmsUreteral NeoplasmsUrethral Neoplasms Wake Forest University Health Sciences 8